IL17A and psoriasis: In previous studies, transgenic mice with STAT3 or RORγt-deficient T cells were reported to exhibit a decrease in Th17 cell infiltration in psoriatic lesions [7], and IL-17A production ameliorated the psoriasis symptoms.